SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 15 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,193,000 | -32.7% | 651,615 | +6.3% | 0.00% | -100.0% |
| Q3 2016 | $4,746,000 | +35.2% | 613,121 | -2.2% | 0.00% | 0.0% |
| Q2 2016 | $3,510,000 | +3.2% | 626,872 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $3,401,000 | -38.1% | 632,177 | +0.3% | 0.00% | 0.0% |
| Q4 2015 | $5,491,000 | +7.9% | 630,424 | +3.9% | 0.00% | 0.0% |
| Q3 2015 | $5,090,000 | -55.4% | 606,641 | -6.3% | 0.00% | -50.0% |
| Q2 2015 | $11,409,000 | +124.2% | 647,506 | +47.1% | 0.00% | +100.0% |
| Q1 2015 | $5,088,000 | +35.9% | 440,155 | +18.4% | 0.00% | 0.0% |
| Q4 2014 | $3,744,000 | +186.7% | 371,815 | +28.7% | 0.00% | – |
| Q3 2014 | $1,306,000 | -21.7% | 288,897 | +16.8% | 0.00% | – |
| Q2 2014 | $1,669,000 | -29.6% | 247,287 | +33.6% | 0.00% | – |
| Q1 2014 | $2,372,000 | +129.0% | 185,053 | +44.7% | 0.00% | – |
| Q4 2013 | $1,036,000 | – | 127,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,799,790 | $11,059,000 | 3.50% |
| Intellectus Partners, LLC | 1,095,840 | $4,329,000 | 2.20% |
| Cormorant Asset Management, LP | 1,690,800 | $6,679,000 | 0.97% |
| Avoro Capital Advisors LLC | 1,192,130 | $4,709,000 | 0.60% |
| Vident Investment Advisory, LLC | 170,534 | $674,000 | 0.07% |
| GAGNON SECURITIES LLC | 11,116 | $44,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 22,000 | $87,000 | 0.02% |
| R&F Capital Advisors LP | 12,878 | $51,000 | 0.01% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 96,154 | $380,000 | 0.01% |
| Virtu KCG Holdings LLC | 27,425 | $108,000 | 0.00% |